Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys

This publication has 21 references indexed in Scilit:

• Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A tyrosine hydroxylase immunocytochemical study in monkey
  Neuroscience, 1986
• Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)
  Neurology, 1985
• The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and Man
  Canadian Journal of Neurological Sciences, 1984
• Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting*
  Acta Physiologica Scandinavica, 1983
• The crossed mesostriatal projection: neurochemistry and developmental response to lesion
  Brain Research, 1983
• Recovery of function and basal ganglia [14C]2-deoxyglucose uptake after nigrostriatal injury
  Brain Research, 1983
• LOCOMOTOR CONTROL IN MACAQUE MONKEYS
  Brain, 1981
• Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions
  Brain Research, 1981
• Chronic parkinsonism secondary to intravenous injection of meperidine analogues
  Psychiatry Research, 1979
• DOPAMINE IN THE BASAL GANGLIA: Its Role and Therapeutic Implications (Including the Clinical Use of L-DOPA)
  British Medical Bulletin, 1973